To further evaluate the activation of the MAPK pathway in vivo, we analyzed the expression of p-p38, p-JNK and p-ERK1/2 in osteosarcoma tissues with or without iron chelator treatment. This evidence concerns the gene MAPK3 and osteosarcoma.